Introduction & Pathogenesis - Bone's Silent Siege
- Etiology: Mycobacterium tuberculosis.
- Spread: Hematogenous from primary focus (lungs > lymph nodes).
- Pathogenesis:
- Bacilli lodge in vascular bone: vertebral bodies, metaphysis/epiphysis, synovium.
- Immune response → granuloma (epithelioid cells, Langhans cells, lymphocytes, caseous necrosis).
- Enzymatic destruction: cartilage (pannus), bone (lytic lesions).
- Results in: juxta-articular osteoporosis, cold abscess, sinus tracts.
- Common sites: Spine (Pott's disease) > Hip > Knee.
⭐ Spine (Pott's disease) is the most common site of skeletal TB.
Clinical Manifestations - TB's Crippling Clues
- General (Constitutional):
- Low-grade fever (evening rise)
- Weight loss, anorexia
- Night sweats, malaise
- Local (Affected Site):
- Pain: insidious, often worse at night (night cries in children), ↑ with activity
- Swelling: initially doughy, may progress to cold abscess
⭐ Cold abscess (lacks acute inflammation signs) is a characteristic feature of musculoskeletal TB.
- Deformity: e.g., kyphosis (Pott's spine), joint contractures
- Stiffness & ↓ range of motion (ROM)
- Muscle wasting (atrophy)
- Sinus tract formation (chronic cases)
- Site-Specific Highlights:
- Pott's Spine: Back pain, tenderness, spinal deformity (gibbus), neurological deficit (Pott's paraplegia)
- TB Hip/Knee: Limp, pain, swelling, restricted movement. oka
Diagnostic Workup - Finding TB's Footprint
- Baseline Bloods: ↑ ESR/CRP; Anemia; Lymphocytosis.
- Immunological Tests:
- Mantoux (TST): >10mm significant (HIV+ >5mm).
- IGRA (e.g., QuantiFERON-TB Gold): More specific. Both indicate exposure, not active disease.
- Imaging:
- X-ray:
- Early: Osteopenia, soft tissue swelling.
- Phemister's Triad (📌 PEM - Periarticular osteoporosis, Erosions peripherally/marginally, Slow joint space narrowing).
- Late: Destruction, deformity.

- MRI:
- Most sensitive for early changes (synovitis, marrow edema, pre-pus).
- Assesses soft tissue, abscesses, cord compression (spine).
⭐ MRI is the most sensitive imaging modality for early detection of osteoarticular TB and assessing soft tissue involvement, including pre-pus stages.
- CT Scan: Details bony destruction, sequestra.
- X-ray:
- Definitive Diagnosis (Gold Standard):
- Synovial Fluid / Pus / Tissue Biopsy:
- AFB Smear: Low sensitivity.
- Culture (LJ medium): Takes 4-6 weeks.
- NAAT (GeneXpert): Rapid, detects MTB & Rifampicin resistance.
- Histopathology (Biopsy): Caseating granulomas.
- Synovial Fluid / Pus / Tissue Biopsy:
Management Strategies - TB Treatment Triumph
- Goals: Eradicate infection, preserve function, prevent deformity.
- Cornerstone: Multi-drug Anti-Tubercular Therapy (ATT).
- 📌 RIPE Regimen: Rifampicin, Isoniazid, Pyrazinamide, Ethambutol.
- Duration: 9-12 months (paucibacillary); 12-18 months (multibacillary/spinal).
- DOTS strategy recommended.
- Supportive Care: Rest, nutrition, analgesia, physiotherapy.
- Surgical Indications:
- Biopsy for diagnosis.
- Drainage of large abscesses.
- Debridement of sequestra/infected tissue.
- Stabilization (spine/joints).
- Deformity correction.
- Salvage procedures (arthrodesis/arthroplasty) for destroyed joints.
⭐ Multi-drug anti-tubercular therapy (ATT) for an extended duration (e.g., 9-18 months depending on site/severity) is the cornerstone of treatment for bone and joint TB.
High‑Yield Points - ⚡ Biggest Takeaways
- Spine (Pott's spine) is the most common site, typically thoracolumbar junction.
- Phemister's triad (juxta-articular osteoporosis, peripheral erosions, joint narrowing) is key radiologically.
- Cold abscess formation is a hallmark; may track along fascial planes.
- Diagnosis: imaging (X-ray, MRI), biopsy/aspirate for AFB, culture, histopathology (caseating granulomas).
- Treatment: Multi-drug anti-tubercular therapy (ATT) for 9-12 months is standard.
- Watch for paradoxical worsening on ATT and gibbus deformity in spinal TB.
Continue reading on Oncourse
Sign up for free to access the full lesson, plus unlimited questions, flashcards, AI-powered notes, and more.
CONTINUE READING — FREEor get the app
